McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK Common Stock Repurchased

Cash spent buying back the company's own shares.

McKesson CorporationNYSE: MCK

Common Stock Repurchased · Q1 FY2027 · quarter ended Jun 2026

Common stock repurchased growth accelerates

Q1 FY2027 common stock repurchased of $2.53B (cash outflow) rose 335.5% year over year, ahead of the +65.6% change in trailing-twelve-month common stock repurchased. Sequentially, it fell 5.3% from the prior quarter. Over 3 fiscal years it compounded at +9.3% a year.

Context

  • Common stock repurchased amounted to 1.2% of revenue in FY2026, up 0.3 pp from a year earlier.
  • Common stock repurchased grew in size in 2 of the last 3 fiscal years.
  • FY2026 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +335.5% holds above the trailing-twelve-month pace of +65.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$2.53B-5.3% QoQ
Last fiscal yearMar 2026
-$4.75B+51.0% YoY
LTMJun 2026
-$5.3B+65.6% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+335.5%——
1 year+51.0%——
3-year CAGR+9.3%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2026
(4.75B) USD
Year-over-year change
-51.0%

Common Stock Repurchased vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's LTM Jun 2026 common stock repurchased of $5.3B is the largest of the 4 companies compared; the peer median is $1B.
  • Its year-over-year change of +65.6% is the 2nd highest of 3, against a peer median of +241.8%.
  • Common stock repurchased amounts to 1.3% of revenue for MCK, versus a peer median of 0.3%.
MCK Competitors Peer median
Common Stock Repurchased for MCK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$5.3B +65.6%+9.3%1.3%
CAHCardinal Health, Inc.LTM Sep 2026$1.48B —-12.1%0.6%
CORCencora, Inc.LTM Jun 2026$1B +6.3%-3.4%0.3%
ACHAccendra Health, Inc.LTM Mar 2026$8.68M +477.2%—0.3%
Peer median (excluding MCK) $1B+241.8%-7.8%0.3%

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income1.29B3.72B3.16B3.48B4.76B
Depreciation & Amortization760M608M635M636M729M
Deferred Income Tax34M(20M)(603M)(110M)230M
Stock-Based Compensation161M162M000
Change in Working Capital82M384M(64M)1.16B162M
Accounts Receivables(1.84B)(1.08B)(2.95B)(3.94B)(2B)
Inventory(1.17B)(1.26B)(1.29B)(2.27B)(1.08B)
Accounts Payables2.8B3.79B004.32B
Other Working Capital292M(1.06B)4.18B7.36B(1.07B)
Other Non-Cash Items2.11B303M1.19B923M272M
Operating Cash Flow4.43B5.16B4.31B6.09B6.16B
Capital Expenditures(535M)(558M)(687M)(859M)(745M)
Acquisitions (Net)572M210M(225M)155M(2.59B)
Purchases of Investments(446M)0000
Sales of Investments446M866M000
Other Investing Activities(126M)(1.06B)(416M)(351M)(101M)
Investing Cash Flow(89M)(542M)(1.07B)(733M)(3.43B)
Debt Repayment(1.15B)(277M)56M(21M)783M
Common Stock Issued220M163M116M101M89M
Common Stock Repurchased(3.52B)(3.64B)(3.03B)(3.15B)(4.75B)
Dividends Paid(277M)(292M)(314M)(345M)(381M)
Other Financing Activities(1.38B)(324M)(175M)(554M)(372M)
Financing Cash Flow(6.32B)(4.37B)(3.34B)(3.97B)(4.63B)
Effect of Forex Changes(485M)495M6M(16M)(73M)
Net Change in Cash(2.46B)744M(94M)1.37B(1.98B)
Free Cash Flow3.9B4.6B3.63B5.23B5.41B

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.